Development of a high throughput functional assay for structure-activity studies of neurokinin A analogs

被引:3
作者
Gembitsky, DS [1 ]
Lovas, S [1 ]
Murphy, RF [1 ]
机构
[1] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA
关键词
D O I
10.1177/108705719800300304
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A great variety of functional assays are in use to evaluate novel ligands of tachykinin receptors, These techniques, however, are generally labor and time consuming and hardly suitable for high throughput screening. Using human recombinant NK-2 receptors expressed in CHO cells, we have developed an assay based on direct measurement of guanine nucleotide exchange on G-proteins, [S-35]GTP gamma S, which cannot be hydrolyzed by the intrinsic GTPase activity of the alpha-subunit of heterotrimeric G-protein, was employed. Six ligands of NK-2 receptors including both natural neurokinins and neurokinin A analogs were used for the assay validation. The assay was shown to discriminate successfully between partial and full agonism, as well as between agonism and antagonism of the peptides. Besides the exquisite specificity and high throughput, the assay obviates the need for laboratory animals and cumbersome muscle-bath techniques for conventional tachykinin pharmacology, The functional GTP gamma S assay is a specific and reliable high throughput screening tool for the investigation of pharmacologic properties of neurokinin A analogs. The assay has multiple advantages over existing techniques and is favored for studies on structure-activity relationships in peptides.
引用
收藏
页码:183 / 188
页数:6
相关论文
共 52 条
[1]   HUNTINGTONS-DISEASE - CHANGES IN TACHYKININ CONTENT IN POSTMORTEM BRAINS [J].
ARAI, H ;
EMSON, PC ;
CARRASCO, LH .
ANNALS OF NEUROLOGY, 1987, 22 (05) :587-594
[2]   FUNCTIONALLY DISTINCT G-PROTEINS SELECTIVELY COUPLE DIFFERENT RECEPTORS TO PL HYDROLYSIS IN THE SAME CELL [J].
ASHKENAZI, A ;
PERALTA, EG ;
WINSLOW, JW ;
RAMACHANDRAN, J ;
CAPON, DJ .
CELL, 1989, 56 (03) :487-493
[3]   AIRWAY NEUROPEPTIDES AND ASTHMA [J].
BARNES, PJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1987, 8 (01) :24-27
[4]   SUBSTANCE-P-LIKE IMMUNOREACTIVITY IS REDUCED IN ALZHEIMERS-DISEASE CEREBRAL-CORTEX [J].
BEAL, MF ;
MAZUREK, MF .
NEUROLOGY, 1987, 37 (07) :1205-1209
[5]  
BRAN MR, 1996, J BIOMOL SCREEN, V1, P43
[6]   Pharmacology of muscarinic acetylcholine receptor subtypes (m1-m5): High throughput assays in mammalian cells [J].
Bräuner-Osborne, H ;
Brann, MR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 295 (01) :93-102
[7]   DECREASE OF VASOACTIVE INTESTINAL PEPTIDE, METHIONINE-ENKEPHALIN, SUBSTANCE-P AND INCREASE OF NEUROPEPTIDE-Y IMMUNOREACTIVE NERVE-FIBERS IN AGANGLIONIC COLON OF HIRSCHSPRUNGS-DISEASE [J].
DELAFT, MH ;
DASSONVILLE, M ;
STEYAERT, H ;
VANDERVEKEN, E ;
LOTSTRA, F ;
VIERENDEELS, G ;
PRZEDBORSKI, S ;
VAUDRY, H ;
VANDERHAEGHEN, JJ .
NEUROCHEMISTRY INTERNATIONAL, 1989, 14 (02) :135-141
[8]   STRUCTURE-ACTIVITY STUDY OF NEUROKININS - ANTAGONISTS FOR THE NEUROKININ-2 RECEPTOR [J].
DION, S ;
ROUISSI, N ;
NANTEL, F ;
JUKIC, D ;
RHALEB, NE ;
TOUSIGNANT, C ;
TELEMAQUE, S ;
DRAPEAU, G ;
REGOLI, D ;
NALINE, E ;
ADVENIER, C ;
ROVERO, P ;
MAGGI, CA .
PHARMACOLOGY, 1990, 41 (04) :184-194
[9]   DIFFERENT RECEPTORS ARE INVOLVED IN THE ENDOTHELIUM-MEDIATED RELAXATION AND THE SMOOTH-MUSCLE CONTRACTION OF THE RABBIT PULMONARY-ARTERY IN RESPONSE TO SUBSTANCE-P AND RELATED NEUROKININS [J].
DORLEANSJUSTE, P ;
DION, S ;
DRAPEAU, G ;
REGOLI, D .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 125 (01) :37-44
[10]  
Erspamer V., 1973, PURE APPL CHEM, V35, P463, DOI [10.1351/pac197335040463, DOI 10.1351/PAC197335040463]